Literature DB >> 11179829

Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models.

N Kunugita1, K Kohshi, Y Kinoshita, T Katoh, H Abe, T Tosaki, T Kawamoto, T Norimura.   

Abstract

We examined the effect of radiotherapy after hyperbaric oxygen (HBO) breathing in experimental tumors using a tumor growth delay assay. Tumor models used were SCCVII (radiobiological hypoxic fraction: approximately 10%) and 9L tumors (containing less hypoxic cells) subcutaneously transplanted into C3H/He mice and Fisher 344 rats, respectively. Irradiation using X-rays was locally administered to the tumors immediately after decompression. HBO breathing enhanced the radiation response in SCCVII tumors but not in 9L ones. In the next experiment using SCCVII tumors, irradiation was administered 5, 15, 30, and 90 min after decompression. A significant growth delay was seen in the treated animals within 30 min after HBO breathing, and the tumor growth delay time was prolonged 1.61 times as long as that in radiotherapy alone. We concluded that: (1) radiotherapy after HBO breathing is effective for tumors with hypoxic cells; and (2) the time lapse from decompression to irradiation is an important factor in improving radiosensitivity. Radiotherapy after HBO breathing can be used to enhance the efficacy of clinical treatments.

Entities:  

Mesh:

Year:  2001        PMID: 11179829     DOI: 10.1016/s0304-3835(00)00721-7

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

Review 1.  Old but new methods in radiation oncology: hyperbaric oxygen therapy.

Authors:  Kazuhiko Ogawa; Kiyotaka Kohshi; Syogo Ishiuchi; Masayuki Matsushita; Naoki Yoshimi; Sadayuki Murayama
Journal:  Int J Clin Oncol       Date:  2013-03-05       Impact factor: 3.402

2.  Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.

Authors:  Kiyotaka Kohshi; Haruaki Yamamoto; Ai Nakahara; Takahiko Katoh; Masashi Takagi
Journal:  J Neurooncol       Date:  2006-11-22       Impact factor: 4.506

3.  Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

Authors:  K Ogawa; Y Yoshii; O Inoue; T Toita; A Saito; Y Kakinohana; G Adachi; S Iraha; W Tamaki; K Sugimoto; A Hyodo; S Murayama
Journal:  Br J Cancer       Date:  2006-09-05       Impact factor: 7.640

4.  Combination of carboplatin and intermittent normobaric hyperoxia synergistically suppresses benzo[a]pyrene-induced lung cancer.

Authors:  Hea Yon Lee; In Kyoung Kim; Hye In Lee; Hwa Young Lee; Hye Seon Kang; Chang Dong Yeo; Hyun Hui Kang; Hwa Sik Moon; Sang Haak Lee
Journal:  Korean J Intern Med       Date:  2017-12-15       Impact factor: 2.884

5.  Role of Hyperbaric Oxygenation Plus Hypofractionated Stereotactic Radiotherapy in Recurrent High-Grade Glioma.

Authors:  Donatella Arpa; Elisabetta Parisi; Giulia Ghigi; Annalisa Cortesi; Pasquale Longobardi; Patrizia Cenni; Martina Pieri; Luca Tontini; Elisa Neri; Simona Micheletti; Francesca Ghetti; Manuela Monti; Flavia Foca; Anna Tesei; Chiara Arienti; Anna Sarnelli; Giovanni Martinelli; Antonio Romeo
Journal:  Front Oncol       Date:  2021-03-30       Impact factor: 6.244

6.  Hyperbaric Oxygen Therapy as a Complementary Treatment in Glioblastoma-A Scoping Review.

Authors:  Diogo Alpuim Costa; Mafalda Sampaio-Alves; Eduardo Netto; Gonçalo Fernandez; Edson Oliveira; Andreia Teixeira; Pedro Modas Daniel; Guilherme Silva Bernardo; Carla Amaro
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.